VICTORY CAPITAL MANAGEMENT INC

Position in NVS — Novartis AG

CIK 1040188 San Antonio, TX

Position in NVS

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$4,632,643

-$779,595 QoQ

Shares Held

29,560

-16.6% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#271

of 1,603 holders

Holding Since

Mar 2023

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

VICTORY CAPITAL MANAGEMENT INC holds $5,636,745,309 across 13 Drug Manufacturers - General names. NVS ranks #11 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	2,141,447	$2,568,515,989
2	JNJ	Johnson & Johnson	2,620,929	$665,637,338
3	BMY	Bristol Myers Squibb Co	10,168,924	$585,933,400
4	MRK	Merck & Co., Inc.	4,143,885	$532,489,222
5	ABBV	AbbVie Inc.	1,581,740	$398,029,053
6	GILD	Gilead Sciences, Inc.	2,203,012	$278,328,536
7	AMGN	Amgen Inc	632,302	$228,969,200
8	PFE	Pfizer Inc	9,152,541	$220,393,187

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$4,632,643	29,560	-16.6%	Shares	Sole	2026-08-07
2026-03-31	$5,412,238	35,432	-30.6%	Shares	Sole	2026-05-15
2025-12-31	$7,035,781	51,032	-32.4%	Shares	Sole	2026-02-13
2025-09-30	$9,677,503	75,464	-3.4%	Shares	Sole	2025-11-12
2025-06-30	$9,451,365	78,104	-36.5%	Shares	Sole	2025-08-13
2025-03-31	$13,715,384	123,030	+27.8%	Shares	Sole	2025-05-02
2024-12-31	$9,365,211	96,241	+1437.4%	Shares	Sole	2025-02-06
2023-12-31	$632,072	6,260	-70.7%	Shares	Sole	2024-02-05
2023-09-30	$2,178,785	21,390	0.0%	Shares	Sole	2023-11-06
2023-06-30	$2,158,464	21,390	-8.1%	Shares	Sole	2023-07-27
2023-03-31	$2,141,116	23,273	—	Shares	Sole	2023-05-02
No filing history on record for this holder in this stock.